IP Library Granted Patent US 9,610,430
Granted Patent B2
US 9,610,430 · App. 14/136,681 · Granted Apr 4, 2017

Cell spraying device, method and sprayed cell suspension

Inventor: Reinhard Bornemann (Bielefeld, DE)
Assignee: RenovaCare Sciences Corp.
A61M37/00A61M35/00A61B2017/00969
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,610,430
App. No.
14/136,681
Granted
Apr 4, 2017
Kind
B2
Abstract

The invention provides a device and methods suitable for producing a cellular spray of cells. The sprayed cells are of interest for covering and growing on a surface, including a skin wound. In applying the method and/or using the device, cells for grafting onto a patient are dispersed in a solution and sprayed with the device for distribution over the recipient's graft site.

Claims (14)

1. A method to treat a wounded area of skin on a human subject, comprising:

providing a single cell-suspension of cells comprising progenitor skin cells in a serum-free physiological solution in a sterilizable container, wherein the cells are obtained from the subject's normal skin tissue that has been treated with enzymes so as to release the cells from the dermal-epithelial cell junction, wherein the skin cells have not been subjected to ex vivo or in vitro expansion;

contacting the single-cell suspension of cells with a gas flow at an outlet of the container to create droplets of the suspension at a flow-controlled spray head; and

spraying the droplets onto the wounded area of skin without forming a closed cell sheet so that the single cells are distributed directly and evenly and the cells regenerate normal skin by in situ multiplication to heal the wounded area in the absence of applying a preformed skin graft.

2. The method of claim 1 wherein the suspension comprises uncultured cell types in a ratio comparable to that found in normal skin.

3. The method of claim 1 or 2 wherein the cells comprise basal keratinocytes, Langerhans cells, fibroblasts and melanocytes.

4. The method of claim 1 wherein the cells in the suspension have a morphology that is similar to the cells in the droplets.

5. The method of claim 2 wherein the suspension comprises skin progenitor cells.

6. The method of claim 1 , wherein the suspension is filtered to remove large cellular congregates.

7. The method of claim 6 , wherein the filter has a cut-off of 5-100 cell congregates.

8. The method of claim 1 wherein the enzymes comprise dispase and trypsin.

9. The method of claim 1 wherein the enzymes comprise collagenase.

10. The method of claim 1 wherein the container is a syringe and the suspension is delivered to the outlet of the spray head by continuous force application to the container.

11. The method of claim 1 wherein the wounded area is burned.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2015
From: BORNEMANN, REINHARD
To: GERLACH, JÖRG C.
Reel/Frame 034867/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2015
From: GERLACH, JÖRG C.
To: JANUS ACQUISITION CORP.
Reel/Frame 034867/0768 →
CHANGE OF NAME Recorded Feb 2, 2015
From: JANUS ACQUISITION CORP.
To: RENOVACARE SCIENCES CORP.
Reel/Frame 034867/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2015
From: BORNEMANN, REINHARD; GERLACH, JORG C.
To: RENOVACARE SCIENCES CORP.
Reel/Frame 034611/0834 →
Continuity (2)
Continuation 11518012 · Sep 11, 2006
Related Publication 20140107621A1 · Apr 17, 2014